Results
|
1741.
|
|
|
1742.
|
|
|
1743.
|
|
|
1744.
|
|
|
1745.
|
|
|
1746.
|
|
|
1747.
|
|
|
1748.
|
|
|
1749.
|
|
|
1750.
|
|
|
1751.
|
Ability of fibrinogen γ-derived dodecapeptides with different sequences to bind to rat platelets. [electronic resource] by
- Tokutomi, Koji
- Tagawa, Toshiaki
- Korenaga, Maki
- Chiba, Masatoshi
- Asai, Tomohiro
- Watanabe, Naohide
- Takeoka, Shinji
- Handa, Makoto
- Ikeda, Yasuo
- Oku, Naoto
Producer: 20130319
In:
International journal of pharmaceutics vol. 438
Availability: No items available.
|
|
1752.
|
|
|
1753.
|
|
|
1754.
|
Appropriate bolus administration of glycoprotein IIb/IIIa inhibitors for patients with acute coronary syndromes undergoing percutaneous coronary intervention: intracoronary or intravenous? A comprehensive and updated meta-analysis and systematic review. [electronic resource] by
- Ali-Hasan-Al-Saegh, Sadeq
- Mirhosseini, Seyed Jalil
- Shahidzadeh, Arezoo
- Rahimizadeh, Elham
- Sarrafan-Chaharsoughi, Zahra
- Ghodratipour, Zahra
- Lotfaliani, Mohammad
- Rezaeisadrabadi, Mohammad
- Dehghan, Hamid Reza
- Bireta, Christian
- Weymann, Alexander
- Sabashnikov, Anton
- Popov, Aron-Frederik
Producer: 20170223
In:
Kardiologia polska vol. 74
Availability: No items available.
|
|
1755.
|
|
|
1756.
|
|
|
1757.
|
Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist. [electronic resource] by
- Duggan, M E
- Duong, L T
- Fisher, J E
- Hamill, T G
- Hoffman, W F
- Huff, J R
- Ihle, N C
- Leu, C T
- Nagy, R M
- Perkins, J J
- Rodan, S B
- Wesolowski, G
- Whitman, D B
- Zartman, A E
- Rodan, G A
- Hartman, G D
Producer: 20001108
In:
Journal of medicinal chemistry vol. 43
Availability: No items available.
|
|
1758.
|
|
|
1759.
|
|
|
1760.
|
|